Abbott Laboratoriesvs.Hologic
ABT vs HOLX · both in Diagnostics, part of the Medicine, pharma & life science value chain: Tests, imaging and assays that support clinical decision-making.
Abbott Laboratories is about 9.6× larger than Hologic by market cap; Abbott Laboratories trades at the lower P/E (26.1 vs 31.2); year to date, Hologic leads (+2.0% vs −25.0%).
Side by side
| ABT | HOLX | |
|---|---|---|
| Market cap | $164B | $17B |
| Price | $93.93 | — |
| Today | −0.5% | — |
| Return YTD | −25.0% | +2.0% |
| Return 1Y | −29.7% | −3.5% |
| P/E | 26.1 | 31.2 |
| P/S | 3.6 | 4.1 |
| P/B | 3.1 | 3.2 |
Data as of 2026-07-11 · updates daily after U.S. close
The two companies
Abbott LaboratoriesABT
American healthcare group with four divisions: diagnostics, medical devices (including glucose monitoring), nutrition and generics.
Full ABT profile →HologicHOLX
American medical technology company focused on women's health — diagnostics, mammography (imaging) and surgery.
Full HOLX profile →More comparisons in Diagnostics
See where ABT and HOLX sit in the full Medicine, pharma & life science map — every segment from suppliers to end markets.Open the Life science value chain →